RAMM Pharma

RAMM Pharma Acquisitions (Net)

Acquisitions (Net) of RAMM Pharma (RAMM.CN) as of Oct 11, 2026.

Acquisitions (Net)

0.00CAD

Last updated:

Acquisitions (Net) of RAMM Pharma is 2024 0.00 CAD. Acquisitions (Net) of RAMM Pharma was 2023 188,800.00 CAD. It decreases by % lower compared to the previous year.

The RAMM Pharma Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
628,400.00 CAD
Jan 1, 2019
115,300.00 CAD
Jan 1, 2020
333,600.00 CAD
Jan 1, 2021
-6.40 M CAD
Jan 1, 2022
-984,000.00 CAD
Jan 1, 2023
188,800.00 CAD
Jan 1, 2024
0.00 CAD
The RAMM Pharma Acquisitions (Net) history
YEARAcquisitions (Net)YoY
0.00CAD-100.00%
188,800.00CAD-119.19%
-984,000.00CAD-84.63%
-6.40 MCAD-2,019.12%
333,600.00CAD+189.33%
115,300.00CAD-81.65%
628,400.00CAD—
Access this data via the Eulerpool API
Get Free API Key

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

On Eulerpool you can find the complete historical development of Acquisitions (Net) RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s RAMM Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — RAMM Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — RAMM Pharma